By blending tumor-intrinsic signals (serum tumor marker, size, multiplicity) with host-response metrics (NLR, albumin, γ-GT), our model captures complementary invasion pathways that neither domain alone can fully describe. The gene discussed is ALB; the disease is neoplasm.